Simple blood test maps hidden Alzheimer’s disease changes
A large community study shows that Alzheimer’s-related brain changes are far more widespread with age than symptoms alone…
Blood-based biomarkers and the new landscape of Alzheimer’s research
For much of the past century, Alzheimer’s disease has been one of medicine’s most daunting frontiers – biologically…
Smartphone motor tests can predict dopamine deficiency in Parkinson’s disease without brain scans
By pairing everyday smartphone motion data with established clinical scores, researchers demonstrate a promising path toward accessible, radiation-free…
Midlife blood test may reveal Alzheimer’s disease risk in advance
A simple blood test for platelet activity at middle age could one day help identify people at risk…
New WashU center aims to transform disease diagnosis through AI imaging
Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis is establishing a new…
Digital test plus blood biomarker boosts accuracy of Alzheimer’s diagnosis in primary care
By confirming cognitive impairment before ordering amyloid blood tests, this two-step approach cuts false positives, streamlines referrals, and…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
Two-step blood and scan strategy delivers near-perfect accuracy for early Alzheimer signs
A simple blood test for p-tau217, when combined with confirmatory brain scans or CSF analysis, could transform early…
New imaging technique enhances live-cell visualization in standard lab setups
Optical diffraction tomography (ODT) has long been recognized for its potential in non-invasive, label-free imaging of live biological…